Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pygmy populations seronegative for Marburg virus.
Borchert M, Mulangu S, Swanepoel R, Tshomba A, Afounde A, Kulidri A, Muyembe-Tamfum JJ, Van der Stuyft P. Borchert M, et al. Among authors: mulangu s. Emerg Infect Dis. 2005 Jan;11(1):174-7. doi: 10.3201/eid1101.040377. Emerg Infect Dis. 2005. PMID: 15714665 Free PMC article. No abstract available.
Serosurvey on household contacts of Marburg hemorrhagic fever patients.
Borchert M, Mulangu S, Swanepoel R, Libande ML, Tshomba A, Kulidri A, Muyembe-Tamfum JJ, Van der Stuyft P. Borchert M, et al. Among authors: mulangu s. Emerg Infect Dis. 2006 Mar;12(3):433-9. doi: 10.3201/eid1203.050622. Emerg Infect Dis. 2006. PMID: 16704781 Free PMC article.
Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment.
Colebunders R, Tshomba A, Van Kerkhove MD, Bausch DG, Campbell P, Libande M, Pirard P, Tshioko F, Mardel S, Mulangu S, Sleurs H, Rollin PE, Muyembe-Tamfum JJ, Jeffs B, Borchert M; International Scientific and Technical Committee "DRC Watsa/Durba 1999 Marburg Outbreak Investigation Group". Colebunders R, et al. Among authors: mulangu s. J Infect Dis. 2007 Nov 15;196 Suppl 2:S148-53. doi: 10.1086/520543. J Infect Dis. 2007. PMID: 17940943
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults.
Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, Koup RA, Roederer M, Bailer R, Mascola JR, Pau MG, Sullivan NJ, Goudsmit J, Nabel GJ, Graham BS; VRC 205 Study Team. Ledgerwood JE, et al. Among authors: mulangu s. Vaccine. 2010 Dec 16;29(2):304-13. doi: 10.1016/j.vaccine.2010.10.037. Epub 2010 Oct 27. Vaccine. 2010. PMID: 21034824 Clinical Trial.
Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge.
Geisbert TW, Bailey M, Hensley L, Asiedu C, Geisbert J, Stanley D, Honko A, Johnson J, Mulangu S, Pau MG, Custers J, Vellinga J, Hendriks J, Jahrling P, Roederer M, Goudsmit J, Koup R, Sullivan NJ. Geisbert TW, et al. Among authors: mulangu s. J Virol. 2011 May;85(9):4222-33. doi: 10.1128/JVI.02407-10. Epub 2011 Feb 16. J Virol. 2011. PMID: 21325402 Free PMC article.
Ebolavirus vaccines for humans and apes.
Fausther-Bovendo H, Mulangu S, Sullivan NJ. Fausther-Bovendo H, et al. Among authors: mulangu s. Curr Opin Virol. 2012 Jun;2(3):324-9. doi: 10.1016/j.coviro.2012.04.003. Epub 2012 May 4. Curr Opin Virol. 2012. PMID: 22560007 Free PMC article. Review.
Ebola virus outbreaks in Africa: past and present.
Muyembe-Tamfum JJ, Mulangu S, Masumu J, Kayembe JM, Kemp A, Paweska JT. Muyembe-Tamfum JJ, et al. Among authors: mulangu s. Onderstepoort J Vet Res. 2012 Jun 20;79(2):451. doi: 10.4102/ojvr.v79i2.451. Onderstepoort J Vet Res. 2012. PMID: 23327370 Review.
36 results